Abstract
This issue of Cancer Discovery features an article that describes the use of whole-genome sequencing to discover an actionable genetic alteration that was not detected using a lower resolution diagnostic approach. This fi nding highlights the growing debate surrounding the optimal deployment of powerful new genomics technologies in the clinical oncology arena. ©2012 American Association for Cancer Research.
Cite
CITATION STYLE
APA
Garraway, L. A., & Baselga, J. (2012). Whole-genome sequencing and cancer therapy: Is too much ever enough? Cancer Discovery, 2(9), 766–768. https://doi.org/10.1158/2159-8290.CD-12-0359
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free